Skip to main content
Fig. 1 | BMC Health Services Research

Fig. 1

From: Risk stratification by endocrinologists of patients with type 2 diabetes in a Danish specialised outpatient clinic: a cross-sectional study

Fig. 1

The Danish risk stratification model for patients with type 2 diabetes. All parameters in level 1 have to be fulfilled to be allocated to risk stratification level 1. At risk stratification level 2 at least one parameter has to be fulfilled in level 2, and none in level 3. Patients at level 3 have to fulfil at least one of the parameters in level 3 [16]. HbA1c, haemoglobin A1c; CVD, cardiovascular disease; MACE, major cardiovascular event; NYHA, the New York Heart Association functional classification in patients with heart disease [38]. a Severe insulin resistance: Insulin dose > 2.0 U/kg/day. b Very fluctuating plasma glucose: Daily plasma glucose values of >15 mmol/l or <5 mmol/l. c Peripheral neuropathy: Vibration perception threshold ≥25 mV evaluated by a biothesiometer. d Peripheral artery disease: Ankle-brachial index <0.9 with or without symptomatic claudication. e Micro-albuminuria: >1 occasion of urine-albumin/creatinine ratio between 30 and 300 mg/g. f Macro-albuminuria:: Urine-albumin/creatinine ratio ≥300 mg/g or an estimated glomerular filtration rate <60 ml/min

Back to article page